Startup founded by UAB professor aims to improve asthma, respiratory diseases
Based the startup's patient trial data, the device reduces asthma and COPD risk attacks by 36% and hospital/ER admission by 27%.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Laurel Thrailkill Source Type: news
More News: Asthma | Chronic Obstructive Pulmonary | Health Management | Hospitals | Pharmaceuticals | Respiratory Medicine